Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors

Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors

US Patent 9598396 · Granted Mar 21, 2017

Estimated economic value: $98,944,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HPK1 inhibitors2025
HPK1 inhibitors2025
Bicyclic HPK1 inhibitors2025
Bicyclic HPK1 inhibitors2025
Compounds useful as inhibitors of ATR kinase2025
GCN2 inhibitors and uses thereof2024
Spiro bicyclic inhibitors of menin-MLL interaction2024
Inhibitors of the interaction between MDM2 and P532023
Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment 2023
Azepane inhibitors of menin-MLL interaction2022
Exo-aza spiro inhibitors of menin-MLL interaction2022
Compounds useful as inhibitors of ATR kinase2022